MGC Pharma receives cannabis cultivation research permit from Australian ODC
SYDNEY: MGC Pharmaceuticals (MXC), a European bio-pharma company specialising in the production and development of phytocannabinoid derived medicines, announced it has been granted a Cannabis...
MGC Pharma signs agreement for entry of cannabinoid medicines into new markets
PERTH: MGC Pharmaceuticals Ltd has signed a distribution agreement with Anden Bio Naturals S.A, a leading Peruvian medical products distributor, for the exclusive distribution and...